|
Quality Compliance Concerns Land DePuy a Warning Letter
The FDA slapped Johnson & Johnson’s DePuy Orthopaedics with a warning letter citing quality system compliance concerns at its Warsaw, Ind., plant, including lack of proper design validation procedures.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives